2019
DOI: 10.1186/s40001-019-0366-9
|View full text |Cite
|
Sign up to set email alerts
|

Human umbilical cord mesenchymal stem cells implantation accelerates cutaneous wound healing in diabetic rats via the Wnt signaling pathway

Abstract: ObjectiveDifficulty in wound healing is one common complication of diabetes mellitus. The study explored whether the therapeutic effect of human umbilical cord mesenchymal stem cells (hUCMSCs) on diabetic ulcer wound was enhanced by the activation of the Wnt signaling pathway.MethodsRat diabetic model was established by intraperitoneal injection of Streptozotocin (STZ). hUCMSCs were purified and seeded on the collagen–chitosan laser drilling acellular dermal matrix (CCLDADM) scaffold, which was subsequently im… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
46
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 47 publications
(49 citation statements)
references
References 26 publications
3
46
0
Order By: Relevance
“…The articles were excluded because of study design, study topic (not diabetic wound), human studies, or studies not report wound healing as outcome measurements. Finally, 29 21,24‐51 studies that evaluated the effect of chitosan or alginate on diabetic wound healing were included. Figure 1 illustrated the trial selection process.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…The articles were excluded because of study design, study topic (not diabetic wound), human studies, or studies not report wound healing as outcome measurements. Finally, 29 21,24‐51 studies that evaluated the effect of chitosan or alginate on diabetic wound healing were included. Figure 1 illustrated the trial selection process.…”
Section: Resultsmentioning
confidence: 99%
“…Table 1 presented the descriptive characteristics of the included articles. Overall, there were 23 trials 21,24‐30,32‐46 on chitosan, three trials on alginate, 31,47,48 and three trials on the combination of alginate and chitosan 49‐51 . The animal studies were conducted from 2002 and 2019.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Currently, WJSCs have clinical application for a broad scope of diseases . Human Wharton's jelly stem cells (hWJSCs) have properties such as robust proliferation and differentiation, and weak immunogenicity, thereby posing a great potential in the field of regenerative medicine . MSCs can be seeded onto several scaffolds providing a three‐dimensional environment for the MSCs to grow and improve the reconstruction of the injured tissues.…”
Section: Introductionmentioning
confidence: 99%
“…14 Human Wharton's jelly stem cells (hWJSCs) have properties such as robust proliferation and differentiation, and weak immunogenicity, thereby posing a great potential in the field of regenerative medicine. 15 MSCs can be seeded onto several scaffolds providing a three-dimensional environment for the MSCs to grow and improve the reconstruction of the injured tissues. These scaffolds were shown to possess properties such as porosity, cytocompatibility, biodegradability, surface physicochemical, and biomechanical activities.…”
Section: Introductionmentioning
confidence: 99%